Citigroup’s Redhill Biopharma RDHL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-5
Closed -$166 4900
2023
Q4
$166 Buy
+5
New +$166 ﹤0.01% 4729
2023
Q1
Sell
-1
Closed -$146 4895
2022
Q4
$146 Hold
1
﹤0.01% 4815
2022
Q3
$1K Sell
1
-4
-80% -$4K ﹤0.01% 4841
2022
Q2
$4K Buy
5
+4
+400% +$3.2K ﹤0.01% 4927
2022
Q1
$3K Hold
1
﹤0.01% 5147
2021
Q4
$4K Sell
1
-1
-50% -$4K ﹤0.01% 4904
2021
Q3
$11K Sell
2
-1
-33% -$5.5K ﹤0.01% 4688
2021
Q2
$19K Buy
3
+2
+200% +$12.7K ﹤0.01% 4662
2021
Q1
$5K Sell
1
-1
-50% -$5K ﹤0.01% 5234
2020
Q4
$15K Buy
2
+1
+100% +$7.5K ﹤0.01% 4751
2020
Q3
$8K Hold
1
﹤0.01% 4447
2020
Q2
$5K Buy
+1
New +$5K ﹤0.01% 4826
2016
Q1
Hold
0
5548
2015
Q4
Hold
0
5609
2015
Q2
Hold
0
5698
2015
Q1
Hold
0
5616
2014
Q2
Hold
0
-$1K 5605
2014
Q1
Hold
0
5333